Bronchocentric granulomatosis: Difference between revisions

Jump to navigation Jump to search
No edit summary
No edit summary
Line 5: Line 5:
   
   
==Overview==
==Overview==
Bronchocentric granulomatosis is not a disease per se but a histopathological finding of the bronchi and bronchioles. It is commonly seen in asthmatic patients with allergic bronchopulmonary aspergillosis, but can also be observed in non-asthmatics with no identifiable etiological agent.<ref name="pmid1092235">{{cite journal| author=Katzenstein AL, Liebow AA, Friedman PJ| title=Bronchocentric granulomatosis, mucoid impaction, and hypersensitivity reactions to fungi. | journal=Am Rev Respir Dis | year= 1975 | volume= 111 | issue= 4 | pages= 497-537 | pmid=1092235 | doi=10.1164/arrd.1975.111.4.497 | pmc= | url=https://www.ncbi.nlm.nih.gov/entrez/eutils/elink.fcgi?dbfrom=pubmed&tool=sumsearch.org/cite&retmode=ref&cmd=prlinks&id=1092235  }} </ref>
Bronchocentric granulomatosis is not a disease per se but a histopathological finding of the bronchi and bronchioles. It is commonly seen in association with asthma and allergic bronchopulmonary aspergillosis, but can also be observed in non-asthmatics with no identifiable etiological agent.<ref name="pmid1092235">{{cite journal| author=Katzenstein AL, Liebow AA, Friedman PJ| title=Bronchocentric granulomatosis, mucoid impaction, and hypersensitivity reactions to fungi. | journal=Am Rev Respir Dis | year= 1975 | volume= 111 | issue= 4 | pages= 497-537 | pmid=1092235 | doi=10.1164/arrd.1975.111.4.497 | pmc= | url=https://www.ncbi.nlm.nih.gov/entrez/eutils/elink.fcgi?dbfrom=pubmed&tool=sumsearch.org/cite&retmode=ref&cmd=prlinks&id=1092235  }} </ref>


==Historical Perspective==
==Historical Perspective==
Line 13: Line 13:


==Pathophysiology==
==Pathophysiology==
*There are two patterns observed in Bronchocentric granulomatosis, the more common pattern is observed in young men with asthma. The less common pattern is seen in older patients who are non-asthmatic. The <ref name="pmid1092235">{{cite journal| author=Katzenstein AL, Liebow AA, Friedman PJ| title=Bronchocentric granulomatosis, mucoid impaction, and hypersensitivity reactions to fungi. | journal=Am Rev Respir Dis | year= 1975 | volume= 111 | issue= 4 | pages= 497-537 | pmid=1092235 | doi=10.1164/arrd.1975.111.4.497 | pmc= | url=https://www.ncbi.nlm.nih.gov/entrez/eutils/elink.fcgi?dbfrom=pubmed&tool=sumsearch.org/cite&retmode=ref&cmd=prlinks&id=1092235  }} </ref>   
*There are two patterns observed in Bronchocentric granulomatosis, the more common pattern is observed in young men with asthma and less common pattern is seen in older patients who are non-asthmatic. The <ref name="pmid1092235">{{cite journal| author=Katzenstein AL, Liebow AA, Friedman PJ| title=Bronchocentric granulomatosis, mucoid impaction, and hypersensitivity reactions to fungi. | journal=Am Rev Respir Dis | year= 1975 | volume= 111 | issue= 4 | pages= 497-537 | pmid=1092235 | doi=10.1164/arrd.1975.111.4.497 | pmc= | url=https://www.ncbi.nlm.nih.gov/entrez/eutils/elink.fcgi?dbfrom=pubmed&tool=sumsearch.org/cite&retmode=ref&cmd=prlinks&id=1092235  }} </ref>   
*On microscopic histopathological analysis, there is central necrotizing granulomatous inflammation of the bronchi and bronchioles.<ref name="pmid1092235">{{cite journal| author=Katzenstein AL, Liebow AA, Friedman PJ| title=Bronchocentric granulomatosis, mucoid impaction, and hypersensitivity reactions to fungi. | journal=Am Rev Respir Dis | year= 1975 | volume= 111 | issue= 4 | pages= 497-537 | pmid=1092235 | doi=10.1164/arrd.1975.111.4.497 | pmc= | url=https://www.ncbi.nlm.nih.gov/entrez/eutils/elink.fcgi?dbfrom=pubmed&tool=sumsearch.org/cite&retmode=ref&cmd=prlinks&id=1092235  }} </ref>  
*On microscopic histopathological analysis, there is central necrotizing granulomatous inflammation of the bronchi and bronchioles.<ref name="pmid1092235">{{cite journal| author=Katzenstein AL, Liebow AA, Friedman PJ| title=Bronchocentric granulomatosis, mucoid impaction, and hypersensitivity reactions to fungi. | journal=Am Rev Respir Dis | year= 1975 | volume= 111 | issue= 4 | pages= 497-537 | pmid=1092235 | doi=10.1164/arrd.1975.111.4.497 | pmc= | url=https://www.ncbi.nlm.nih.gov/entrez/eutils/elink.fcgi?dbfrom=pubmed&tool=sumsearch.org/cite&retmode=ref&cmd=prlinks&id=1092235  }} </ref>  
   
   
==Causes==
==Causes==
* [Disease name] may be caused by either [cause1], [cause2], or [cause3].
* Bronchocentric granulomatosis can be idiopathic or caused by other diseases including asthma and allergic bronchopulmonary aspergillosis. <ref name="pmid7275101">{{cite journal| author=Koss MN, Robinson RG, Hochholzer L| title=Bronchocentric granulomatosis. | journal=Hum Pathol | year= 1981 | volume= 12 | issue= 7 | pages= 632-8 | pmid=7275101 | doi= | pmc= | url=https://www.ncbi.nlm.nih.gov/entrez/eutils/elink.fcgi?dbfrom=pubmed&tool=sumsearch.org/cite&retmode=ref&cmd=prlinks&id=7275101  }} </ref>
* [Disease name] is caused by a mutation in the [gene1], [gene2], or [gene3] gene[s].
* There are no established causes for [disease name].
   
   
==Differentiating [disease name] from other Diseases==
==Differentiating [disease name] from other Diseases==
Line 31: Line 29:
   
   
===Age===
===Age===
*Patients of all age groups may develop Bronchocentric granulomatosis.
*Patients of all age groups may develop Bronchocentric granulomatosis.  
 
*[Disease name] is more commonly observed among patients aged [age range] years old.
*Bronchocentric granulomatosis is more commonly observed among elderly patients.
===Gender===
===Gender===
*[Disease name] affects men and women equally.
*Bronchocentric granulomatosis affects men and women equally.
*[Gender 1] are more commonly affected with [disease name] than [gender 2].
* The [gender 1] to [Gender 2] ratio is approximately [number > 1] to 1.
   
   
===Race===
===Race===
*There is no racial predilection for [disease name].
*There is no racial predilection for Bronchocentric granulomatosis.
*[Disease name] usually affects individuals of the [race 1] race.
*[Race 2] individuals are less likely to develop [disease name].
   
   
==Risk Factors==
==Risk Factors==
*Common risk factors in the development of [disease name] are [risk factor 1], [risk factor 2], [risk factor 3], and [risk factor 4].
*Common risk factors in the development of Bronchocentric granulomatosis are [risk factor 1], [risk factor 2], [risk factor 3], and [risk factor 4].
 
== Natural History, Complications and Prognosis==
*The majority of patients with [disease name] remain asymptomatic for [duration/years].
*Early clinical features include [manifestation 1], [manifestation 2], and [manifestation 3].
*If left untreated, [#%] of patients with [disease name] may progress to develop [manifestation 1], [manifestation 2], and [manifestation 3].
*Common complications of [disease name] include [complication 1], [complication 2], and [complication 3].
*Prognosis is generally [excellent/good/poor], and the [1/5/10­year mortality/survival rate] of patients with [disease name] is approximately [#%].
   
   
== Diagnosis ==
== Diagnosis ==
===Diagnostic Criteria===
===Diagnostic Criteria===
*The diagnosis of [disease name] is made when at least [number] of the following [number] diagnostic criteria are met:
:*[criterion 1]
:*[criterion 2]
:*[criterion 3]
:*[criterion 4]
   
   
=== Symptoms ===
=== Symptoms ===
Line 76: Line 54:
   
   
=== Physical Examination ===
=== Physical Examination ===
*Patients with [disease name] usually appear [general appearance].
*Physical examination may be remarkable for:
:*[finding 1]
:*[finding 2]
:*[finding 3]
:*[finding 4]
:*[finding 5]
:*[finding 6]
   
   
=== Laboratory Findings ===
=== Laboratory Findings ===
*There are no specific laboratory findings associated with [disease name].
*There are no specific laboratory findings associated with Bronchocentric granulomatosis.


*A  [positive/negative] [test name] is diagnostic of [disease name].
*An [elevated/reduced] concentration of [serum/blood/urinary/CSF/other] [lab test] is diagnostic of [disease name].
*Other laboratory findings consistent with the diagnosis of [disease name] include [abnormal test 1], [abnormal test 2], and [abnormal test 3].
*Other laboratory findings consistent with the diagnosis of [disease name] include [abnormal test 1], [abnormal test 2], and [abnormal test 3].
   
   
===Imaging Findings===
===Imaging Findings===
*There are no [imaging study] findings associated with [disease name].
*[Imaging study 1] is the imaging modality of choice for [disease name].
*On [imaging study 1], [disease name] is characterized by [finding 1], [finding 2], and [finding 3].
*[Imaging study 2] may demonstrate [finding 1], [finding 2], and [finding 3].
   
   
*CT is the imaging modality of choice for Bronchocentric granulomatosis.
*On CT, Bronchocentric granulomatosis is characterized by focal mass or lobar consolidation with atelectasis.<ref name="pmid10767190">{{cite journal| author=Ward S, Heyneman LE, Flint JD, Leung AN, Kazerooni EA, Müller NL| title=Bronchocentric granulomatosis: computed tomographic findings in five patients. | journal=Clin Radiol | year= 2000 | volume= 55 | issue= 4 | pages= 296-300 | pmid=10767190 | doi=10.1053/crad.1999.0380 | pmc= | url=https://www.ncbi.nlm.nih.gov/entrez/eutils/elink.fcgi?dbfrom=pubmed&tool=sumsearch.org/cite&retmode=ref&cmd=prlinks&id=10767190  }} </ref>
=== Other Diagnostic Studies ===
=== Other Diagnostic Studies ===
*[Disease name] may also be diagnosed using [diagnostic study name].
*Bronchocentric granulomatosis may also be diagnosed using open lung biopsy.
*Findings on [diagnostic study name] include [finding 1], [finding 2], and [finding 3].
*Findings on open lung biopsy include [finding 1], [finding 2], and [finding 3].
   
   
== Treatment ==
== Treatment ==
=== Medical Therapy ===
=== Medical Therapy ===
*There is no treatment for [disease name]; the mainstay of therapy is supportive care.
*The mainstay of therapy for Bronchocentric granulomatosis is corticosteroids. An anti fungal agent should be given if there is an underlying fungal infection.<ref name="pmid7275101">{{cite journal| author=Koss MN, Robinson RG, Hochholzer L| title=Bronchocentric granulomatosis. | journal=Hum Pathol | year= 1981 | volume= 12 | issue= 7 | pages= 632-8 | pmid=7275101 | doi= | pmc= | url=https://www.ncbi.nlm.nih.gov/entrez/eutils/elink.fcgi?dbfrom=pubmed&tool=sumsearch.org/cite&retmode=ref&cmd=prlinks&id=7275101 }} </ref><ref name="pmid6852779">{{cite journal| author=Jelihovsky T| title=The structure of bronchial plugs in mucoid impaction, bronchocentric granulomatosis and asthma. | journal=Histopathology | year= 1983 | volume= 7 | issue= 2 | pages= 153-67 | pmid=6852779 | doi= | pmc= | url=https://www.ncbi.nlm.nih.gov/entrez/eutils/elink.fcgi?dbfrom=pubmed&tool=sumsearch.org/cite&retmode=ref&cmd=prlinks&id=6852779  }} </ref>
   
 
*The mainstay of therapy for [disease name] is [medical therapy 1] and [medical therapy 2].
*[Medical therapy 1] acts by [mechanism of action 1].
*Response to [medical therapy 1] can be monitored with [test/physical finding/imaging] every [frequency/duration].
   
   
=== Surgery ===
=== Surgery ===
Line 117: Line 80:
   
   
=== Prevention ===
=== Prevention ===
*There are no primary preventive measures available for [disease name].
*There are no primary preventive measures available for Bronchocentric granulomatoiss.
*Effective measures for the primary prevention of [disease name] include [measure1], [measure2], and [measure3].
 
*Once diagnosed and successfully treated, patients with [disease name] are followed-up every [duration]. Follow-up testing includes [test 1], [test 2], and [test 3].  


==References==
==References==

Revision as of 17:17, 28 December 2018

WikiDoc Resources for Bronchocentric granulomatosis

Articles

Most recent articles on Bronchocentric granulomatosis

Most cited articles on Bronchocentric granulomatosis

Review articles on Bronchocentric granulomatosis

Articles on Bronchocentric granulomatosis in N Eng J Med, Lancet, BMJ

Media

Powerpoint slides on Bronchocentric granulomatosis

Images of Bronchocentric granulomatosis

Photos of Bronchocentric granulomatosis

Podcasts & MP3s on Bronchocentric granulomatosis

Videos on Bronchocentric granulomatosis

Evidence Based Medicine

Cochrane Collaboration on Bronchocentric granulomatosis

Bandolier on Bronchocentric granulomatosis

TRIP on Bronchocentric granulomatosis

Clinical Trials

Ongoing Trials on Bronchocentric granulomatosis at Clinical Trials.gov

Trial results on Bronchocentric granulomatosis

Clinical Trials on Bronchocentric granulomatosis at Google

Guidelines / Policies / Govt

US National Guidelines Clearinghouse on Bronchocentric granulomatosis

NICE Guidance on Bronchocentric granulomatosis

NHS PRODIGY Guidance

FDA on Bronchocentric granulomatosis

CDC on Bronchocentric granulomatosis

Books

Books on Bronchocentric granulomatosis

News

Bronchocentric granulomatosis in the news

Be alerted to news on Bronchocentric granulomatosis

News trends on Bronchocentric granulomatosis

Commentary

Blogs on Bronchocentric granulomatosis

Definitions

Definitions of Bronchocentric granulomatosis

Patient Resources / Community

Patient resources on Bronchocentric granulomatosis

Discussion groups on Bronchocentric granulomatosis

Patient Handouts on Bronchocentric granulomatosis

Directions to Hospitals Treating Bronchocentric granulomatosis

Risk calculators and risk factors for Bronchocentric granulomatosis

Healthcare Provider Resources

Symptoms of Bronchocentric granulomatosis

Causes & Risk Factors for Bronchocentric granulomatosis

Diagnostic studies for Bronchocentric granulomatosis

Treatment of Bronchocentric granulomatosis

Continuing Medical Education (CME)

CME Programs on Bronchocentric granulomatosis

International

Bronchocentric granulomatosis en Espanol

Bronchocentric granulomatosis en Francais

Business

Bronchocentric granulomatosis in the Marketplace

Patents on Bronchocentric granulomatosis

Experimental / Informatics

List of terms related to Bronchocentric granulomatosis

Editor-In-Chief: C. Michael Gibson, M.S., M.D. [1] Associate Editor(s)-in-Chief: Nikhila Palle, M.B.B.S


Overview

Bronchocentric granulomatosis is not a disease per se but a histopathological finding of the bronchi and bronchioles. It is commonly seen in association with asthma and allergic bronchopulmonary aspergillosis, but can also be observed in non-asthmatics with no identifiable etiological agent.[1]

Historical Perspective

  • Bronchocentric granulomatosis was first discovered by Liebow, in 1973.[2]

Classification

Pathophysiology

  • There are two patterns observed in Bronchocentric granulomatosis, the more common pattern is observed in young men with asthma and less common pattern is seen in older patients who are non-asthmatic. The [1]
  • On microscopic histopathological analysis, there is central necrotizing granulomatous inflammation of the bronchi and bronchioles.[1]

Causes

  • Bronchocentric granulomatosis can be idiopathic or caused by other diseases including asthma and allergic bronchopulmonary aspergillosis. [3]

Differentiating [disease name] from other Diseases

  • Bronchocentric granulomatosis must be differentiated from other diseases that cause fever, cough and chest pain, such as:
  • Tuberculosis
  • [Differential dx2]
  • [Differential dx3]

Epidemiology and Demographics

  • The incidence and prevalence of Bronchocentric granulomatosis is not known.

Age

  • Patients of all age groups may develop Bronchocentric granulomatosis.

Gender

  • Bronchocentric granulomatosis affects men and women equally.

Race

  • There is no racial predilection for Bronchocentric granulomatosis.

Risk Factors

  • Common risk factors in the development of Bronchocentric granulomatosis are [risk factor 1], [risk factor 2], [risk factor 3], and [risk factor 4].


Diagnosis

Diagnostic Criteria

Symptoms

  • Symptoms of Bronchocentric granulomatosis may include the following:
  • Cough
  • Wheezing
  • Fever
  • Dyspnea
  • Blood eosinophilia


Physical Examination

Laboratory Findings

  • There are no specific laboratory findings associated with Bronchocentric granulomatosis.
  • Other laboratory findings consistent with the diagnosis of [disease name] include [abnormal test 1], [abnormal test 2], and [abnormal test 3].

Imaging Findings

  • CT is the imaging modality of choice for Bronchocentric granulomatosis.
  • On CT, Bronchocentric granulomatosis is characterized by focal mass or lobar consolidation with atelectasis.[4]

Other Diagnostic Studies

  • Bronchocentric granulomatosis may also be diagnosed using open lung biopsy.
  • Findings on open lung biopsy include [finding 1], [finding 2], and [finding 3].

Treatment

Medical Therapy

  • The mainstay of therapy for Bronchocentric granulomatosis is corticosteroids. An anti fungal agent should be given if there is an underlying fungal infection.[3][5]


Surgery

  • Surgery is the mainstay of therapy for [disease name].
  • [Surgical procedure] in conjunction with [chemotherapy/radiation] is the most common approach to the treatment of [disease name].
  • [Surgical procedure] can only be performed for patients with [disease stage] [disease name].

Prevention

  • There are no primary preventive measures available for Bronchocentric granulomatoiss.

References

  1. 1.0 1.1 1.2 Katzenstein AL, Liebow AA, Friedman PJ (1975). "Bronchocentric granulomatosis, mucoid impaction, and hypersensitivity reactions to fungi". Am Rev Respir Dis. 111 (4): 497–537. doi:10.1164/arrd.1975.111.4.497. PMID 1092235.
  2. Liebow AA (1973). "The J. Burns Amberson lecture--pulmonary angiitis and granulomatosis". Am Rev Respir Dis. 108 (1): 1–18. doi:10.1164/arrd.1973.108.1.1. PMID 4577269.
  3. 3.0 3.1 Koss MN, Robinson RG, Hochholzer L (1981). "Bronchocentric granulomatosis". Hum Pathol. 12 (7): 632–8. PMID 7275101.
  4. Ward S, Heyneman LE, Flint JD, Leung AN, Kazerooni EA, Müller NL (2000). "Bronchocentric granulomatosis: computed tomographic findings in five patients". Clin Radiol. 55 (4): 296–300. doi:10.1053/crad.1999.0380. PMID 10767190.
  5. Jelihovsky T (1983). "The structure of bronchial plugs in mucoid impaction, bronchocentric granulomatosis and asthma". Histopathology. 7 (2): 153–67. PMID 6852779.